Tag: Shelf life,

Follow these instructions to conduct stability studies effectively on various pharmaceutical dosage forms: General Considerations: For each dosage form: Evaluate appearance, assay, and degradation products. Limit degradation product testing for generic products to compendial requirements. Note: The listed tests are not exhaustive. Not every test needs to be included in the stability protocol. Consider safety…

Read More “Guide to Conducting Stability Studies on Pharmaceutical Dosage Forms” »

Drugs with low solubility present unique challenges in stability studies due to their limited aqueous solubility, which can affect dissolution, bioavailability, and stability under various storage conditions. Conducting stability studies for such drugs requires careful consideration of formulation strategies, analytical methods, and regulatory requirements to ensure accurate assessment of product stability and shelf life. Key…

Read More “Stability Studies for Drugs with Low Solubility” »

Regulatory Requirements for Stability Studies in Different Regions Stability studies are an integral part of the drug development process, ensuring the safety, efficacy, and quality of pharmaceutical products throughout their shelf life. Regulatory agencies in different regions, including the United States, Europe, and other countries, have established guidelines and requirements for conducting stability studies to…

Read More “Regulatory requirements for stability studies” »

Peptides and proteins are biopharmaceuticals with complex structures and delicate chemical properties. Stability studies for peptides and proteins are crucial for assessing their physical, chemical, and biological stability under various storage conditions. These studies provide valuable insights into the degradation pathways, formulation optimization, and shelf-life determination of peptide and protein-based therapeutics. Key Considerations When conducting…

Read More “Stability Studies for Peptides and Proteins” »

Considerations for Stability Studies of Complex Dosage Forms Complex dosage forms, such as extended-release formulations, liposomal formulations, and combination products, present unique challenges in stability studies due to their intricate compositions, varied release mechanisms, and susceptibility to degradation. Conducting stability studies for complex dosage forms requires careful consideration of formulation characteristics, manufacturing processes, and regulatory…

Read More “Conducting stability studies for complex dosage Forms” »

Significance of Relative Humidity in Stability Studies Relative humidity (RH) is a critical environmental parameter that influences the stability and quality of pharmaceutical products. In stability studies, controlling and monitoring RH levels are essential for assessing the impact of moisture on product stability, degradation kinetics, and packaging integrity. Understanding the significance of RH in stability…

Read More “Importence of Relative Humidity” »

Addressing Potential Interactions with Packaging Materials in Stability Studies Packaging materials play a crucial role in maintaining the stability and quality of pharmaceutical products during storage and distribution. However, interactions between the product and packaging materials can occur, leading to degradation, contamination, or changes in product composition. Stability studies are conducted to assess and mitigate…

Read More “Interactions between Drug products and packaging materials” »

Shelf life and expiration date are terms commonly used to indicate the period during which a product remains stable and suitable for use. While both are determined through stability studies, they represent different aspects of product stability and quality. Shelf Life Shelf life refers to the duration for which a product maintains its intended quality,…

Read More “Difference Between Shelf Life and Expiration Date” »